Received: from mail1.rit.ee (213.184.53.4) by DB1PEPF000509FC.mail.protection.outlook.com (10.167.242.38) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.451.8 via Frontend Transport; Mon, 21 Sep 2026 07:41:24 +0000 Received: from DB1PEPF000509FC.eurprd03.prod.outlook.com (2603:10a6:10:552:cafe::82) by DU7P189CA0023.outlook.office365.com (2603:10a6:10:552::16) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.428.16 via Frontend Transport; Mon, 21 Sep 2026 07:41:25 +0000 Received: from AS8P191MB1640.EURP191.PROD.OUTLOOK.COM ([fe80::bfc1:338e:9560:c32e]) by AS8P191MB1640.EURP191.PROD.OUTLOOK.COM ([fe80::bfc1:338e:9560:c32e%5]) with mapi id 15.21.0428.015; Mon, 21 Sep 2026 07:41:19 +0000 Received: from AS8P191MB1640.EURP191.PROD.OUTLOOK.COM (2603:10a6:20b:2e5::6) by AM0P191MB0691.EURP191.PROD.OUTLOOK.COM (2603:10a6:20b:157::7) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.428.16; Mon, 21 Sep 2026 07:41:19 +0000 Received: from DU7P189CA0023.EURP189.PROD.OUTLOOK.COM (2603:10a6:10:552::16) by MI9PR02MB105101.eurprd02.prod.outlook.com (2603:10a6:290:c2::7) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.428.16; Mon, 21 Sep 2026 07:41:25 +0000 Received: from MI9PR02MB105101.eurprd02.prod.outlook.com (2603:10a6:290:c2::7) by MRWPR02MB12112.eurprd02.prod.outlook.com with HTTPS; Mon, 21 Sep 2026 07:41:28 +0000 From: =?iso-8859-15?Q?Aive_M=F5ttus?= To: "press - AKI" Subject: =?iso-8859-15?Q?Palve_tervishoiut=F6=F6tajate_uudisteportaalis_Med24?= Date: Mon, 21 Sep 2026 10:41:19 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_024F_01DD49D5.65FAF470" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQHdSZi90TyrxeWirku23Mhf5Z7BuQ== Authentication-Results: spf=softfail (sender IP is 213.184.53.4) smtp.mailfrom=celsius.ee; dkim=pass (signature was verified) header.d=Celsiushealthcare.onmicrosoft.com;dmarc=fail action=none header.from=celsius.ee;compauth=pass reason=130 X-CSE-ConnectionGUID: BsWhEVdqSryJ3iJEpflH4A== X-CSE-MsgGUID: scZamtzrSRG7q0oOa82BrQ== X-IronPort-AV: E=Sophos;i="6.27,114,1787000400"; d="scan'208,217";a="80552722" X-MS-Exchange-Organization-Network-Message-Id: 4f386316-fb26-447d-6f16-08df17b3bd09 X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: AS8P191MB1640:EE_|AM0P191MB0691:EE_|DB1PEPF000509FC:EE_|MI9PR02MB105101:EE_|MRWPR02MB12112:EE_ X-MS-Exchange-Organization-AuthSource: DB1PEPF000509FC.eurprd03.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: 4f386316-fb26-447d-6f16-08df17b3bd09 X-MS-Exchange-AtpMessageProperties: SA|SL X-Microsoft-Antispam: BCL:0;ARA:13230040|82310400026|260918215300599003|260918224100599003|31052699007|35042699022|10067099003|56012099006|5063699009|18003699003|19002099009|16102099003|55112099003|11063799006|8096899003|13003099007; X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(82310400026)(260918215300599003)(260918224100599003)(31052699007)(35042699022)(10067099003)(56012099006)(5063699009)(18003699003)(19002099009)(16102099003)(55112099003)(11063799006)(8096899003)(13003099007);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 21 Sep 2026 07:41:24.5974 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 4f386316-fb26-447d-6f16-08df17b3bd09 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DB1PEPF000509FC.eurprd03.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: MI9PR02MB105101 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.0657876 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0428.008 X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710232)(4717077)(4999285)(920097)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: =?iso-8859-15?Q?Q51RgfW/dNnQ9JKhjZLOT++ctKh53KCLQuMiYMc4E3KECLGFyVgnMP4vc?= =?iso-8859-15?Q?dL5P5O5SQKXcR3vNFQ5Ga91FEGvsvO7BeIozJcfVvHzwOVCF/Hd0vmNr7?= =?iso-8859-15?Q?5cCRAXKZiGB1GJF7N/RvmgKaxp4hkhiOizLbeEBKpp2xrR//gfEYr3f6c?= =?iso-8859-15?Q?G3MF0WHMbYT6U2qDq4rI9ZLEC2cJNDW0foVuuQ/3N0yV69p8ppoXJ8EJz?= =?iso-8859-15?Q?ClECs8DmbJtPML2m/jqcCSLrmrrRiXfKAk6dmfRbYOJZ7WHT9NGUlfQgu?= =?iso-8859-15?Q?wlFACDV0w+5n2fJpVEfv/dYafRhC9T+qou7fjxlAbkWiqDAdWFgszX4Xp?= =?iso-8859-15?Q?5GkHNl1f8RhEnYtudBeQKIeaXaYZjlPi9/QqA1sVR8hKwPYnUS85t60R8?= =?iso-8859-15?Q?PPhdqt/JdHNNee1IrRr8kyCgd1pgo0Y76pH65hGEbKJ+XlBtkNnHdD+Dz?= =?iso-8859-15?Q?4AiAshca6aJviyE3uS+6sCdkAwJ0KQzLc9U45wy0vkpgVnUvHuY+xMQuj?= =?iso-8859-15?Q?1PVgNKoOesIzLVPqmkXR96/bH4PoSmzKN8uJn7cwe743GBRll+TNyi9Vo?= =?iso-8859-15?Q?J8Wt+t2cdsErfy9Pey/Kk6NMua6FYPVwMUqbAOH7l6EuP2Db5wR+PWQw2?= =?iso-8859-15?Q?2EU8BOWfUdQ/v/ELO62fuDU4n6H5if0QRz5VdPQpJlu56pSrYdF2yNZJk?= =?iso-8859-15?Q?FAxP7/yk+vQYzRRDBqIwHZ7qZ2eHy1r01B9MUjXOWNZhfRqu 9a3Bz2/2w?= =?iso-8859-15?Q?2n0iFrap9h5JrIgxTWgKnzCwkON1Z7K9JHdWqYZZuGjZotwEUjeLOcXVx?= =?iso-8859-15?Q?UMj+eCpRkWzJXIR12TcUF/o2cIAAcdxhsVXRcZJL2923HopPyapM968vO?= =?iso-8859-15?Q?e1yUGX8oZQ4dVxDTssaBKabkBs4XidRTavOgIe9I82VNL27rZHqT3Y4G3?= =?iso-8859-15?Q?vmHpfMQ6WsSwBHyuG2pVd44DfiVx5i/7BiD5Gt2h8w5Kva5n1qbfFWGGO?= =?iso-8859-15?Q?E8XNWBX6fHncy4FtjuUMRKzKPL/Hn/tDNjmSs5kLcCot/Ww8iAtwyExzh?= =?iso-8859-15?Q?+Mr0ubCG/EueidgpI+E6r7mUvbYArhT6IbhRLO3MxOR0Fy6nC56nQ/Flp?= =?iso-8859-15?Q?ivkojquW38g1X1IjeDx09yNvBuEuN9ck4P9K7pADR2ipgenGzCryCeY8Z?= =?iso-8859-15?Q?ztA40R7eSXg2YizWFtMoCsSDujslsW1m8v214hlcWAj4Zv2lx+2wpItKD?= =?iso-8859-15?Q?XOu0aSYR+isUvMb1+mE/LO1FuruQRG7bMrRd4bXYFfbVB5V2RyVzv3pjn?= =?iso-8859-15?Q?M0e8Mg5/u/W/qPP7WccMQteaRYq9MDso2pbcWN9ybnmYIOOy8cuQdsgI4?= =?iso-8859-15?Q?30Kjw2o67k8QQGvvvdEBOHe1Yk39rkLzGB7yRs+kghdl9SiPSqVdSawln?= =?iso-8859-15?Q?w61qW51Sp3G35fQ6C/ODqMPXgwfCdBPO+HVSWST9prTu0G6VdSn4wjpEB?= =?iso-8859-15?Q?ipLixpBFZ/rUO+BgIqhp8PkppROX3Nprt3 l3qZSoA1ULFfK+egb70jZo9?= =?iso-8859-15?Q?121M71Gcf9QDwxqomoZ+Z5yCXk2YDbz5Rq9S2MKj8tUd9pYCT3/gft9ll?= =?iso-8859-15?Q?0V9oSPkthd5WK/e/Z2UfeXZILawxw5FzMm8ASnwB+JTjdkMvPhrY0wW5c?= =?iso-8859-15?Q?hMHbJy9/h9caePe/MEvgoPJSAQ6ksNkimQUItoz3oMjT7MPf2b+NFwG1r?= =?iso-8859-15?Q?kDr5r6eFQgTMllE3llEQqqe4Crz7BFrNz3uFvkO8hkQIfYMxv2yihFEOs?= =?iso-8859-15?Q?AdDN28ka9eDXuOAE4hQOddGW3xBoLDszIMjBa6ux7n2ZYRy1l+g2Mx+vw?= =?iso-8859-15?Q?/j5lmwQ0PNqod4+PjwSvH0b7X2Wv5CW2/j8dqpU3N8q2+B2sOgwUpuXvB?= =?iso-8859-15?Q?cCnyCkZQYI8QyzizsrrPAcaoyiPSBQO7QcfW1XdmYr9AS2Mffmom6t9Jp?= =?iso-8859-15?Q?WoBdfDBCGnXx1/Z3BKq84BPx0UpQL8wY8JbpTFQY3GjwvUI1ZBbzNjKtR?= =?iso-8859-15?Q?S8PvLHkRT+dO7ukg9/ZvMM5zbeeF7l4mwtAtnZOdHPgrZHljEwuxxnWP+?= =?iso-8859-15?Q?rbZFVLvsFhBx1xngr28kHCmXIYeDVfFWByBo4BeWr0nYzl8T+A6N8cfkj?= =?iso-8859-15?Q?ZWmHoQqWkaqQfYzMu3C7ls/EFosTf+Kmol0fllZJJiGBYlyZslEdmWNGO?= =?iso-8859-15?Q?OpuwnLFqb/aGIVGoe88XkA2QltI03a4RU5QY8PDZ343roNoiowPs7Z69G?= =?iso-8859-15?Q?PrEYsH4SaPy/0NDGGqki UWDFHkakS7+OWAKe7fkfWXfsR1aBYGfMnpKuP?= =?iso-8859-15?Q?9WTmgea5vtDnlXHGLLqlUjGnuotOI5LClq+9t/5q/G0xNMij99P50QE62?= =?iso-8859-15?Q?pI9gAgsbpEQsXuIrz+liZZieyAlQFfLu6+SN7z35UT6CKOVm75CliKU2w?= =?iso-8859-15?Q?1QXUX35uQm028CwaS/z6QGN/pQeGnwh9CVdPBGNTuVULBy006EOCvef/p?= =?iso-8859-15?Q?b0F7v3So04Fl7hggow5TNxHKWyzmx8g1FdGCGEGOz5eVkeYPKmH+v3DY4?= =?iso-8859-15?Q?SJ27RmFEV850V6BC9KD2DR2puvT7kcveCoBbZPYa45n3bvUu8NwJIAXoQ?= =?iso-8859-15?Q?HvHpMm0wNWNPDkylF5yxJuU371LV7UF3NhQBtcwtLPm6npbmuTChOE7IR?= =?iso-8859-15?Q?ez53BTwrISCVHadUb4vlYnwTp/tvYStZnwF2ZSdreflTiYIr93Pltz720?= =?iso-8859-15?Q?koTgexOjr77gUHVCpEcuID+gfe6Q1Kpp8WAJnrcyP47fE8z9TJQ4CYcT9?= =?iso-8859-15?Q?onDUQDipZx3o/PcXE/ZSe/N2b1bA8qn/V/D9hU1ctI7FLHsj6nFFSc74h?= =?iso-8859-15?Q?Hhkp3Au6fyxQosYKi/A4NVlENlp73CXbX38CyUT7WvTKK5wz/ef7IwLxs?= =?iso-8859-15?Q?LZ++qFVsizwAnORZoqKOI7zHUefhz6lIXvDW8rwCerBEKRNz/fsvAnzl0?= =?iso-8859-15?Q?jmxb761Gk=3D?= Content-Language: et x-ms-exchange-organization-originalclientipaddress: 213.184.53.4 x-ms-exchange-organization-originalserveripaddress: 10.167.242.38 received-spf: Pass (mail1.rit.ee: domain of postmaster@DB3PR0202CU003.outbound.protection.outlook.com designates 52.101.84.112 as permitted sender) identity=helo; client-ip=52.101.84.112; receiver=mail1.rit.ee; envelope-from="aive@celsius.ee"; x-sender="postmaster@DB3PR0202CU003.outbound.protection.outlook.com"; x-conformance=spf_only; x-record-type="v=spf1"; x-record-text="v=spf1 ip4:40.92.0.0/15 ip4:40.107.0.0/16 ip4:52.100.0.0/15 ip4:52.102.0.0/16 ip4:52.103.0.0/17 ip4:104.47.0.0/17 ip6:2a01:111:f400::/48 ip6:2a01:111:f403::/49 ip6:2a01:111:f403:8000::/51 ip6:2a01:111:f403:c000::/51 ip6:2a01:111:f403:f000::/52 -all" dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=Celsiushealthcare.onmicrosoft.com; s=selector2-Celsiushealthcare-onmicrosoft-com; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=lq6vvU74oPluDDbYRAvleIolbHarzAmgeyceaevcUKY=; b=kGlRmR57JZdp4GnVAtvkvP/6ZJ6Bt4Pv/QDKHHdHumSC087XjOdVxpQ4c9Nf2WgAOcWpEHGVR50lNgA44IiWZETYY3ial5IyGh0VnObzV43njGq4rFqOpsFKAUWr86RU05HP6qkI3IGk4b/z0aZ3E4vu29/9ccEhMDWP1339TRo= X-MS-Has-Attach: X-MS-TNEF-Correlator: x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 acceptlanguage: et-EE, en-US arc-seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none; b=FG2nLvOvDknl/TCuf+Dpva87OHQ422m+I085IuCO5NKtx4GWobMvLy+wUQiRUREkakVGCwW3VUJDLfD3RPZ8BX82njWhzsL7riNYdbxPyt26szEOwImSq4J1t73LFs4QAz68fqZw5gLb9phaIelJ48XN7hlbLS2sowzPAcfaV4TGp3hypeg0KuzeUqYkNRV1jb+jpOnxfxY3m7tuQfPCGTpLUFDBNjME1DyoY6D71ZIO7k3sWLzERHDa/Axu2Q3691kgaJTWQFtGbi/AHaKsDY9B2Is1GCKklQQADy39h0g4evQcamaQU2fFZcXjpCJmiecjiIYfhNIh2EL+59lmhw== arc-message-signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector10001; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=lq6vvU74oPluDDbYRAvleIolbHarzAmgeyceaevcUKY=; b=cIIzFGIgbrSRSd/7io9ykGjBKrT9/hfNSpx/YnaNlkNR2WuBETrDDbwpI0RR0BpMPZVrHDCycEp7b/dC+ac4m2IafM+n5yM2YKv6XjaisysnBnsLo/vsYKWbYtsXYVTwCxI670tbWv/GeYzaTSSzVMbdaleqs86NVOiq5HvPfxT0AH0npcxzLOkjCT+lvdB72rYZp/xgzMBxyG07aCHzQhRi2+wKM1kN/Gant+zKYxUoIGdR0wCekE/rjRrYtEjQAnhuw1c5owibZAxitPNczsQ0U2ZIbHurkZP48r0JeDB5Oqs5IyPnE2ysRlidYyHtI2qKNTjXWXR9n9LbCRb72Q== arc-authentication-results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=celsius.ee; dmarc=pass action=none header.from=celsius.ee; dkim=pass header.d=celsius.ee; arc=none msip_labels: X-Message-Flag: =?iso-8859-15?Q?J=E4reltegevus?= x-ms-exchange-organization-recordreviewcfmtype: 0 This is a multipart message in MIME format. ------=_NextPart_000_024F_01DD49D5.65FAF470 Content-Type: text/plain; charset="iso-8859-15" Content-Transfer-Encoding: 8bit Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere! Viimasel ajal jagavad mõned arstid erinevates sotsiaalmeediakanalites oma patsientide vereanalüüside tulemusi, piltdiagnostikaülesvõtteid, anamneese, diagnoose, ravitulemusi jm, väites, et kuna patsiendi nime kogu selle info juures pole, on kõik anonüümne ning tegevus igati aktsepteeritav, eetiline ning vastab andmekaitsereeglitele. Lisaks kinnitatakse mõnikord, et terviseandmete jagamiseks on olemas patsiendi luba ning viidatakse, et näiteid haigusjuhtudest jagatakse ka tervishoiutöötajatele mõeldud konverentsidel, ajakirjades jm. Kuna teema on tundlik ning võib mõnedes, ehk isegi üsna paljudes patsientides tervishoiusüsteemi vastu usaldamatust tekitada (info jõuab arsti kabinetist sotsiaalmeediasse), uurin, kas te palun saaksite selgitada terviseandmete kogumise eesmärki ja põhimõtteid ning nende anonümiseeritud kujul avaldamist? Mida andmekaitsereeglid sellise tegevuse kohta ütlevad? Kas sotsiaalmeedias, erialastel konverentsidel ja erialaajakirjades anonüümsete terviseandmete/haigusjuhtude jagamine on samaväärne tegevus (arvestades erinevaid auditooriume) või mitte? Kas anonüümsete terviseandmete/haigusjuhtude avalikuks jagamiseks on vaja patsiendi luba? Kui jah, siis millisel kujul ja kuidas see peab vormistatud olema? Avaldaksime Andmekaitse Inspektsiooni seisukoha Med24-s, mis on tervishoiutöötajatele suunatud uudisteportaal. Usun, et sellest oleks selguse loomisel suur abi. Med24 uudiseid saavad lugejad lugeda tasuta, tuleb vaid registreeruda. Heade soovidega ning tagasisidet oodates Aive Mõttus Med24 toimetaja Celsius Healthcare Olevimägi 16, Tallinn 10123 Tel (+372) 5079962 E-mail aive @celsius.ee www.celsius.ee Parem tervishoid läbi parema kommunikatsiooni ------=_NextPart_000_024F_01DD49D5.65FAF470 Content-Type: text/html; charset="iso-8859-15" Content-Transfer-Encoding: quoted-printable

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.
Tere!

Viimasel ajal jagavad m=F5ned arstid erinevates sotsiaalmeediakanalites = oma patsientide vereanal=FC=FCside tulemusi, = piltdiagnostika=FClesv=F5tteid, anamneese, diagnoose, ravitulemusi jm, = v=E4ites, et kuna patsiendi nime kogu selle info juures pole, on k=F5ik = anon=FC=FCmne ning tegevus igati aktsepteeritav, eetiline ning vastab = andmekaitsereeglitele. Lisaks kinnitatakse m=F5nikord, et terviseandmete = jagamiseks on olemas patsiendi luba ning viidatakse, et n=E4iteid = haigusjuhtudest jagatakse ka tervishoiut=F6=F6tajatele m=F5eldud = konverentsidel, ajakirjades jm. 

Kuna teema on tundlik ning v=F5ib m=F5nedes, ehk isegi =FCsna paljudes = patsientides tervishoius=FCsteemi vastu usaldamatust tekitada (info = j=F5uab arsti kabinetist sotsiaalmeediasse), uurin, kas te palun = saaksite selgitada terviseandmete kogumise eesm=E4rki ja p=F5him=F5tteid ning nende anon=FCmiseeritud kujul avaldamist? Mida andmekaitsereeglid = sellise tegevuse kohta =FCtlevad? Kas sotsiaalmeedias, erialastel = konverentsidel ja erialaajakirjades anon=FC=FCmsete = terviseandmete/haigusjuhtude jagamine on samav=E4=E4rne tegevus = (arvestades erinevaid auditooriume) v=F5i mitte?

Kas anon=FC=FCmsete terviseandmete/haigusjuhtude avalikuks jagamiseks on = vaja patsiendi luba? Kui jah, siis millisel kujul ja kuidas see peab = vormistatud olema?

Avaldaksime Andmekaitse Inspektsiooni seisukoha Med24-s, mis on = tervishoiut=F6=F6tajatele suunatud uudisteportaal. Usun, et sellest = oleks selguse loomisel suur abi.

Med24 uudiseid saavad lugejad lugeda tasuta, tuleb vaid = registreeruda. 

Heade soovidega ning tagasisidet oodates

Aive M=F5ttus

Med24 toimetaja

 

Celsius Healthcare

Olevim=E4gi 16, Tallinn 10123

Tel (+372) 5079962

E-mail aive@celsius.ee

www.celsius.ee

 

Parem tervishoid l=E4bi parema = kommunikatsiooni


------=_NextPart_000_024F_01DD49D5.65FAF470--